Cargando…
Novel Cellular and Immunotherapy: Toxicities and Perioperative Implications
Targeted cellular and immunotherapies have welcomed a new chapter in multi-modal cancer therapy. These agents harness our innate immune system and destroy malignant cells in a precise way as compared with “legacy” chemotherapeutic agents that largely rely on abolishing cell division. New therapies c...
Autores principales: | De Camilli, Alessandro, Fischer, Gregory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453139/ https://www.ncbi.nlm.nih.gov/pubmed/37623035 http://dx.doi.org/10.3390/curroncol30080554 |
Ejemplares similares
-
Recent Advances in Perioperative Immunotherapies in Lung Cancer
por: Fukuda, Shota, et al.
Publicado: (2023) -
Role of perioperative immunotherapy in localized renal cell carcinoma
por: Kaur, Jasmeet, et al.
Publicado: (2023) -
Perioperative venous thromboembolic disease and the emerging role of the novel oral anticoagulants: An analysis of the implications for perioperative management
por: Mookadam, Martina, et al.
Publicado: (2015) -
Cellular Immunotherapy and the Lung
por: Daly, Sorcha, et al.
Publicado: (2021) -
Cellular immunotherapy for medulloblastoma
por: Schakelaar, Michael Y, et al.
Publicado: (2022)